Irvine, CA, June 05, 2015 --(PR.com)-- Truinject Corp.™ is pleased to announce the development of the TruInject Platform, the first injectable simulation system featuring true-to-life tissue, 3D digital facial anatomy and real-time feedback.
“TruInject was founded to help healthcare professionals improve patient safety by creating the first certified injection platform in the area of facial aesthetics — bringing a higher level of integrity to individual physicians and practices. Our corporate mission and partnerships align with people who share our values and commitment to patient safety,” Founder and CEO, Gabrielle Rios.
Last week, the FDA issued a warning concerning complications with cosmetic fillers about the possibility of rare, but serious, injuries that may occur due to unintentional injection of soft tissue filler into blood vessels in the face. These occurrences could block the vessels and restrict blood supply to tissues, potentially causing problems such as vision impairment, blindness and stroke.
“It is critical that every healthcare provider that uses dermal fillers has a clear understanding of the anatomical features of the proposed treatment area in order to reduce the incidence of adverse outcomes,” according to Dr. Steve Yoelin, Ophthalmologist and national trainer for injectables. “The TruInject Platform will be the first and only device of its kind that has the unique ability to 'adapt' to new products, new procedures and new injection techniques. This device will help to ensure that adverse events will be minimized.”
The TruInject Platform consists of an anatomical face model, a smart syringe, and a comprehensive analytical software application with built-in 3D facial anatomy. This comprehensive platform facilitates continuous practice at all skill levels. TruInject is the only injector training platform designed to teach the accurate use of injectables, allowing physicians to become experts while enhancing patient safety and outcomes.
“The TruInject Platform offers the most advanced technology for teaching and understanding facial anatomy. I personally am passionate about teaching anatomy and the importance this platform will make regarding patient safety with injectables,” said Dr. Susan Weinkle, Dermatologist and Past-President of the American Society of Dermatologic Surgery (ASDS).